DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker ...
PacBio, developer of advanced sequencing technologies, has announced innovations to its Revio and Vega platforms designed to ...
Alison.ai is launching Creative Genome: an Agentic AI strategist for marketing teams to assist with data-led video generation ...
Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...
| Build smarter healthcare apps, faster. See how clinical data repositories help developers unlock clinical data and drive ...
Press Trust of India on MSN
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the ...
New research using data from the TwinsUK cohort has helped reveal how naturally occurring DNA mutations in healthy tissue may ...
US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...
A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph ...
Dr. Joyce O'Shaughnessy discusses the monarchE trial's findings, emphasizing the importance of abemaciclib in reducing breast cancer recurrence and improving patient access. Joyce O'Shaughnessy, MD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback